AR012341A1 - Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos - Google Patents

Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos

Info

Publication number
AR012341A1
AR012341A1 ARP980101559A ARP980101559A AR012341A1 AR 012341 A1 AR012341 A1 AR 012341A1 AR P980101559 A ARP980101559 A AR P980101559A AR P980101559 A ARP980101559 A AR P980101559A AR 012341 A1 AR012341 A1 AR 012341A1
Authority
AR
Argentina
Prior art keywords
estra
dien
manufacture
pharmaceutical composition
same
Prior art date
Application number
ARP980101559A
Other languages
English (en)
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR012341A1 publication Critical patent/AR012341A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980101559A 1997-04-07 1998-04-06 Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos AR012341A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83533697A 1997-04-07 1997-04-07
US85057097A 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
AR012341A1 true AR012341A1 (es) 2000-10-18

Family

ID=27125779

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101559A AR012341A1 (es) 1997-04-07 1998-04-06 Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos

Country Status (15)

Country Link
EP (1) EP0973790B1 (de)
JP (1) JP2001518896A (de)
KR (1) KR20010006118A (de)
CN (1) CN1259137A (de)
AR (1) AR012341A1 (de)
AT (1) ATE242263T1 (de)
AU (1) AU738486B2 (de)
BR (1) BR9809748A (de)
CA (1) CA2286457A1 (de)
DE (1) DE69815329T2 (de)
DK (1) DK0973790T3 (de)
ES (1) ES2200334T3 (de)
NZ (1) NZ500217A (de)
PT (1) PT973790E (de)
WO (1) WO1998045315A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441252A1 (en) * 2001-03-16 2002-10-10 Wyeth Estrogen replacement therapy
EP2268655A4 (de) * 2008-03-24 2013-03-13 Signa Chemistry Llc Birch-reduktion von steroidsubstraten über alkalimetall-kieselgel-materialien
MX2015000347A (es) 2012-07-10 2015-04-14 Bayer Pharma AG Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos.
PE20151754A1 (es) 2013-02-21 2015-12-20 Bayer Pharma AG Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2930805A (en) * 1959-01-19 1960-03-29 American Home Prod Novel derivatives of estrane
DE1093360B (de) * 1958-02-17 1960-11-24 Ayerst Mckenna & Harrison Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe
US3340278A (en) * 1965-05-03 1967-09-05 American Home Prod 5(10), 7-estradiene-3, 17-dione and the process for the production thereof
SG41955A1 (en) * 1992-04-07 1997-08-15 Neurim Pharma 1991 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia

Also Published As

Publication number Publication date
BR9809748A (pt) 2000-06-20
DE69815329T2 (de) 2004-04-29
CA2286457A1 (en) 1998-10-15
JP2001518896A (ja) 2001-10-16
ATE242263T1 (de) 2003-06-15
WO1998045315A1 (en) 1998-10-15
DE69815329D1 (de) 2003-07-10
DK0973790T3 (da) 2003-09-22
EP0973790B1 (de) 2003-06-04
CN1259137A (zh) 2000-07-05
AU738486B2 (en) 2001-09-20
NZ500217A (en) 2001-11-30
ES2200334T3 (es) 2004-03-01
PT973790E (pt) 2003-10-31
EP0973790A1 (de) 2000-01-26
KR20010006118A (ko) 2001-01-26
AU6946298A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
BR9609738A (pt) Composições para aplicação de droga para estabilidade melhorada de esteróides
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT1033981E (pt) Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos
UY26244A1 (es) Nuevos derivados de quinuclidina y composiciones farmacéuticas que los contienen.
BR9810495A (pt) Composição farmacêutica
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
ATE450254T1 (de) Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
AR012341A1 (es) Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
CO4940457A1 (es) Composiciones farmaceuticas que comprenden sensibilizadores a insulina para tratamiento de la diabetes
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
AR015375A1 (es) Derivados de estrenos, el uso de los mismos para la manufactura de un medicamento, y composicion farmaceutica que los comprende.
IT1243751B (it) Derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
AR031104A1 (es) Composicion farmaceutica que comprende un carboxialquileter y un agente antihipertensivo, primera composicion para su uso con una segunda composicion que comprenden un agente antihipertensivo y un carboxialquileter respectivamente, equipo que comprende un carboxialquileter y un agente antihipertensi
AR012639A1 (es) Estradieno de anillo b, su uso para la manufactura de un medicamento y composicion farmaceutica que lo contiene.
PT1090028E (pt) 14,15-ciclopropano-androstanos insaturados processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos

Legal Events

Date Code Title Description
FB Suspension of granting procedure